- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 5.1 Opinion of Goodwin Procter LLP
- 12.1 Calculation of Ratios of Earnings to Fixed Charges
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Bdo Seidman, LLP
- 23.2 Consent of Bdo Seidman, LLP
- 23.3 Consent of Deloitte and Touche LLP
- 25.1 Form T-1 Statement of Eligibility
- 99.1 Form Letter of Transmittal
- 99.2 Form Notice of Guaranteed Delivery
- 99.3 Form Letter to Registered Holders and DTC Participants
- 99.4 Form Letter to Clients
- 14 Feb 05 Registration of securities issued in business combination transactions (amended)
- 14 Feb 05 Registration of securities issued in business combination transactions (amended)
- 9 Feb 05 Registration of securities issued in business combination transactions
- 1 Jul 04 Registration of securities issued in business combination transactions
- 25 Apr 03 Registration of securities issued in business combination transactions (amended)
- 7 Nov 02 Registration of securities issued in business combination transactions
- 19 Oct 01 Registration of securities issued in business combination transactions (amended)
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Inverness Medical Innovations, Inc.
Waltham, MA
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-4 of Inverness Medical Innovations, Inc. (the “Company”) of our report dated February 17, 2004 (except for the restatements as discussed in Note 2(g), as to which the date is April 19, 2004) relating to the consolidated financial statements of Inverness Medical Innovations, Inc. appearing in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2003.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO Seidman, LLP
Boston, Massachusetts
June 30, 2004